101 related articles for article (PubMed ID: 9314640)
21. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma.
Wayner DD; Burton GW; Ingold KU; Barclay LR; Locke SJ
Biochim Biophys Acta; 1987 Jun; 924(3):408-19. PubMed ID: 3593759
[TBL] [Abstract][Full Text] [Related]
22. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
Kahn SR; Solymoss S; Flegel KM
CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553
[TBL] [Abstract][Full Text] [Related]
23. Hypercoagulability state in patients with chronic obstructive pulmonary disease. Chronic Obstructive Bronchitis and Haemostasis Group.
Alessandri C; Basili S; Violi F; Ferroni P; Gazzaniga PP; Cordova C
Thromb Haemost; 1994 Sep; 72(3):343-6. PubMed ID: 7855781
[TBL] [Abstract][Full Text] [Related]
24. Ascorbyl free radical release in diabetic patients.
Courderot-Masuyer C; Lahet JJ; Verges B; Brun JM; Rochette L
Cell Mol Biol (Noisy-le-grand); 2000 Dec; 46(8):1397-401. PubMed ID: 11156484
[TBL] [Abstract][Full Text] [Related]
25. Coagulation and fibrinolysis markers and risk of dementia. The Dutch Vascular Factors in Dementia Study.
Bots ML; Breteler MM; van Kooten F; Haverkate F; Meijer P; Koudstaal PJ; Grobbee DE; Kluft C
Haemostasis; 1998; 28(3-4):216-22. PubMed ID: 10420069
[TBL] [Abstract][Full Text] [Related]
26. Differential antioxidant status among Indo-Asians compared with caucasians with and without diabetes. Wolverhampton Diabetes Research Group.
Wen Y; Sahni A; Rea CA; Zhang XH; Khokher MA; Singh BM
Diabetes Care; 2000 Feb; 23(2):254-5. PubMed ID: 10868841
[No Abstract] [Full Text] [Related]
27. Markers of plasma coagulation and fibrinolysis after acute deep venous thrombosis.
Meissner MH; Zierler BK; Bergelin RO; Chandler WC; Manzo RA; Strandness DE
J Vasc Surg; 2000 Nov; 32(5):870-80. PubMed ID: 11054218
[TBL] [Abstract][Full Text] [Related]
28. N-3 fatty acids modulate antioxidant status in diabetic rats and their macrosomic offspring.
Yessoufou A; Soulaimann N; Merzouk SA; Moutairou K; Ahissou H; Prost J; Simonin AM; Merzouk H; Hichami A; Khan NA
Int J Obes (Lond); 2006 May; 30(5):739-50. PubMed ID: 16418759
[TBL] [Abstract][Full Text] [Related]
29. Influence of aging on the activity of the hemostatic system: prothrombin fragment 1+2, thrombin-antithrombin III complexes and D-dimers in 80 healthy subjects with age ranging from 20 to 94 years.
Cadroy Y; Pierrejean D; Fontan B; Sié P; Boneu B
Nouv Rev Fr Hematol (1978); 1992; 34(1):43-6. PubMed ID: 1523099
[TBL] [Abstract][Full Text] [Related]
30. Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women.
Peverill RE; Teede HJ; Malan E; Kotsopoulos D; Smolich JJ; McGrath BP
Clin Sci (Lond); 2007 Nov; 113(9):383-91. PubMed ID: 17608627
[TBL] [Abstract][Full Text] [Related]
31. Elevated levels of prothrombin fragment 1 + 2 indicate high risk of thrombosis.
Ota S; Wada H; Abe Y; Yamada E; Sakaguchi A; Nishioka J; Hatada T; Ishikura K; Yamada N; Sudo A; Uchida A; Nobori T
Clin Appl Thromb Hemost; 2008 Jul; 14(3):279-85. PubMed ID: 18160575
[TBL] [Abstract][Full Text] [Related]
32. A fluorescence-based method for measuring total plasma antioxidant capability.
Ghiselli A; Serafini M; Maiani G; Azzini E; Ferro-Luzzi A
Free Radic Biol Med; 1995 Jan; 18(1):29-36. PubMed ID: 7896168
[TBL] [Abstract][Full Text] [Related]
33. Prothrombin fragment 1.2 and modified antithrombin as predictors of disseminated intravascular coagulation and thrombotic risk in thermal injury.
Kowal-Vern A; Walenga JM; Hoppensteadt D; Gamelli RL
J Burn Care Res; 2013; 34(4):459-64. PubMed ID: 23202877
[TBL] [Abstract][Full Text] [Related]
34. Human plasma antioxidant capacity during radiotherapy for lung cancer: a clinical study.
Erhola M; Nieminen MM; Ojala A; Metsä-Ketelä T; Kellokumpu-Lehtinen P; Alho H
J Exp Clin Cancer Res; 1998 Sep; 17(3):325-30. PubMed ID: 9894770
[TBL] [Abstract][Full Text] [Related]
35. Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement.
Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
Thromb Haemost; 1998 Mar; 79(3):509-10. PubMed ID: 9531030
[TBL] [Abstract][Full Text] [Related]
36. High dose supplementation of RRR-alpha-tocopherol decreases cellular hemostasis but accelerates plasmatic coagulation in type 2 diabetes mellitus.
Ferber P; Moll K; Koschinsky T; Rösen P; Susanto F; Schwippert B; Tschöpe D
Horm Metab Res; 1999 Dec; 31(12):665-71. PubMed ID: 10668920
[TBL] [Abstract][Full Text] [Related]
37. Coagulation activation markers in the prediction of venous thrombosis after elective hip surgery.
Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
Thromb Haemost; 1997 Feb; 77(2):267-9. PubMed ID: 9157579
[TBL] [Abstract][Full Text] [Related]
38. Influence of long term oral anticoagulants upon prothrombin fragment 1 + 2, thrombin-antithrombin III complex and D-Dimer levels in patients affected by proximal deep vein thrombosis.
Elias A; Bonfils S; Daoud-Elias M; Gauthier B; Sié P; Boccalon H; Boneu B
Thromb Haemost; 1993 Apr; 69(4):302-5. PubMed ID: 8497840
[TBL] [Abstract][Full Text] [Related]
39. Fibrin D-dimer, markers of coagulation activation and the risk of major ischaemic heart disease in the caerphilly study.
Lowe GD; Rumley A; Sweetnam PM; Yarnell JW; Rumley J
Thromb Haemost; 2001 Sep; 86(3):822-7. PubMed ID: 11583314
[TBL] [Abstract][Full Text] [Related]
40. Total radical-trapping antioxidant potential in gestational diabetes.
Kharb S
Int J Gynaecol Obstet; 2008 Dec; 103(3):257-8. PubMed ID: 18755456
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
